# Discovery of Exoticoumarins A–L: New Anti-Inflammatory Coumarin Derivatives from Murraya exotica

**Authors:** Feng Wu, Zhan-Tao Zhao, Dai-Lin Tang, Bing-Ying Zheng, Nan An, Long Jiang, Lu Gan, Sheng Yin, Jia-Luo Huang, Gui-Hua Tang

PMC · DOI: 10.3390/ijms27052200 · 2026-02-26

## TL;DR

Researchers discovered twelve new anti-inflammatory compounds from Murraya exotica, with two showing strong potential to inhibit inflammation by targeting specific cellular pathways.

## Contribution

The discovery of twelve new coumarin derivatives, including exoticoumarins A and K, which potently inhibit inflammation through JNK pathway suppression.

## Key findings

- Exoticoumarins A and K inhibited nitric oxide production with IC50 values of 7.41 and 10.63 μM.
- Exoticoumarin A suppressed iNOS expression at both transcriptional and translational levels.
- The anti-inflammatory effect of exoticoumarin A was linked to JNK pathway inhibition without affecting ERK 1/2 phosphorylation.

## Abstract

The ethanolic extract of the roots of Murraya exotica (Rutaceae) yielded twenty coumarins, including twelve previously undescribed compounds named exoticoumarins A–L (1–12; two biscoumarins, five coumarin hybrids, and five monomers). Their structures, including absolute configurations, were elucidated by a combination of NMR and HR-ESI-MS analyses, single-crystal X-ray diffraction, ECD exciton coupling, Mo2(OAc)4- and Rh2(OCOCF3)4-induced ECD, comparison of experimental with calculated ECD spectra, and chemical hydrolysis. Anti-inflammatory evaluation in LPS-stimulated RAW264.7 macrophages identified exoticoumarins A and K (1 and 11) as potent inhibitors of nitric oxide (NO) production, with IC50 values of 7.41 and 10.63 μM, respectively. Mechanistic studies revealed that 1 suppressed nitric oxide synthase (iNOS) expression at both transcriptional and translational levels, an effect associated with the inhibition of c-Jun N-terminal kinase (JNK) phosphorylation within the mitogen-activated protein kinase (MAPK) signaling pathways, without markedly affecting extracellular regulated protein kinases (ERK) 1/2 phosphorylation. These findings highlight exoticoumarin A (1) as a promising anti-inflammatory lead derived from M. exotica.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2), MAPK8 (mitogen-activated protein kinase 8), erk1/2 (mitogen-activated protein kinase)
- **Chemicals:** nitric oxide (PubChem CID 145068), doxorubicin (PubChem CID 31703)
- **Species:** Murraya exotica (taxon 2901850)

## Full-text entities

- **Genes:** MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}
- **Diseases:** inflammatory (MESH:D007249), Inflammatory Coumarin Derivatives (MESH:C536683)
- **Chemicals:** Mo2(OAc)4 (MESH:C437387), coumarin (MESH:C030123), coumarins (MESH:D003374), LPS (MESH:D008070), Exoticoumarins A-L (-), NO (MESH:D009569)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984409/full.md

---
Source: https://tomesphere.com/paper/PMC12984409